#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transitional cell cancer of the renal pelvis and ureter Hodgkin's disease recurrent Dilated cardiomyopathy Liver abscess Macular telangiectasia Anti-myelin-associated glycoprotein antibodies positive Salivary gland cancer Chronic graft versus host disease in liver Philadelphia chromosome positive Liposarcoma metastatic Vaginal cancer Squamous cell carcinoma of the hypopharynx Follicle centre lymphoma follicular grade I II – III refractory Myelodysplastic syndrome Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Noonan syndrome – Life with Disease Pulmonary fibrosis – Diagnostics Undifferentiated sarcoma – Treatment Mantle cell lymphoma stage III – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Activated PI3 kinase delta syndrome VEXAS syndrome – Treatment Stevens-Johnson syndrome – Life with Disease Cytokine release syndrome – Trials in Disease Propionic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRONTINEMAB Ofloxacin Charcoal, Activated Midostaurin Ketotifen Hydrogen Fumarate Captopril Lysine Aspirin Etravirine Islatravir HRS 9531 Bepirovirsen Allogeneic Faecal Microbiota Levofloxacin Hemihydrate DROSPIRENONE Bilastine Pervi-Neo ALXN1920 Tilmanocept GSKVX000000046019 Pevonedistat More therapies…

    Learn about Your Condition

    Head and neck cancer stage IV Noninfective chorioretinitis Meniscus injury Erosive oesophagitis Septic shock Hand dermatitis Wolfram syndrome Glucose tolerance impaired Meningioma malignant Polycythaemia vera Cholecystitis acute Adenocarcinoma Dent's disease Hypersomnia Thymic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rhabdomyosarcoma

  • Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Sarcoma
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • Trabectedin
    • Irinotecan Hydrochloride Trihydrate
    Spain

  • Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months – 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    • Rhabdoid tumour
    • Neuroblastoma
    Investigated Drugs:
    • Ribociclib
    • Temozolomide
    • Topotecan Hydrochloride
    Czechia Denmark France Germany Hungary Italy +1

  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primitive neuroectodermal tumour
    • Ewing’s sarcoma
    • Glioma
    Investigated Drugs:
    • Lenvatinib
    Czechia France Italy Spain

  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    • Ependymoma
    • Neuroblastoma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Capecitabine
    • Cyclophosphamide
    France

  • Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Melanoma recurrent
    • Hodgkin’s disease
    • Hepatic cancer
    Investigated Drugs:
    • Cobolimab
    • Dostarlimab
    Czechia Denmark France Germany Italy Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!